Yuyu Pharma, Inc. (KRX:000220)
4,645.00
0.00 (0.00%)
At close: Apr 17, 2025, 3:30 PM KST
Yuyu Pharma Revenue
In the year 2024, Yuyu Pharma had annual revenue of 133.15B KRW, down -2.96%. Yuyu Pharma had revenue of 32.97B in the quarter ending December 31, 2024, a decrease of -4.75%.
Revenue
133.15B
Revenue Growth
-2.96%
P/S Ratio
0.57
Revenue / Employee
526.27M
Employees
253
Market Cap
75.49B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 133.15B | -4.06B | -2.96% |
Dec 31, 2023 | 137.21B | -1.67B | -1.20% |
Dec 31, 2022 | 138.88B | 23.23B | 20.08% |
Dec 31, 2021 | 115.66B | 17.54B | 17.87% |
Dec 31, 2020 | 98.12B | 7.24B | 7.97% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Biologics | 4,547.32B |
Celltrion | 3,557.30B |
ALTEOGEN | 102.85B |
Yuhan | 2,067.79B |
SK Biopharmaceuticals | 547.60B |
HLB Co., Ltd. | 68.13B |
LigaChem Biosciences | 125.90B |
Peptron | 3.15B |